NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/07/2024
Voltar para busca
Dado oficial do USPTO
SYNETS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
30/07/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/02/2023
Data de registro
30/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/07/2024
Última transação
30/07/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Alexandria, AU
Examinador
BECHHOFER, YOCHEVED
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Biogency Pty Ltd
Representantes
Jennifer A. Visintine THOMPSON COBURN LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Food supplementsanti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2024
ALIE
ASSIGNED TO LIE
09/04/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/11/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/11/2023
GNSL
LETTER OF SUSPENSION E-MAILED
12/11/2023
CNSL
SUSPENSION LETTER WRITTEN
12/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2023
DOCK
ASSIGNED TO EXAMINER
01/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/02/2023
NWAP
NEW APPLICATION ENTERED
07/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNETS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.